Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The Food and Drug Administration on Friday approved a new use for Otsuka Pharmaceutical Co.'s drug Abilify Maintena.
Last month's worldwide cyberattack "NotPetya" forced Merck to halt drug production, reports Reuters.
The following drug companies made headlines this past week.
Apace Packaging, a Fountain Run, Ky.-based pharmaceutical packaging company, recalled two medications over labeling issues.
Companies are increasingly struggling to hire individuals with the right skill sets to run their supply chains, according to a new report from DHL.
Here are the three latest drugs or medical devices approved by the Food and Drug Administration this week.
The Food and Drug Administration on Wednesday approved Eisai's epilepsy drug Fyompa as a primary treatment for partial-onset seizures in epileptic patients 12 years or older.
Johnson City, Tenn.-based Crown Laboratories must halt the manufacturing and distribution of various prescription and over-the-counter skin creams following a complaint filed by the Department of Justice on behalf of the Food and Drug Administration.
San Francisco-based McKesson released its financial results for the first quarter of fiscal year 2018, which ended June 30.
Here are six articles published by Becker's Hospital Review this week, featuring Salt Lake City-based Intermountain Healthcare's adoption of a needle-free blood draw technology, the 10 most popular prescription drugs in 2017 and more.